Gelesis awarded $10.6 million grant to support commercial manufacturing of PLENITY
BOSTON: Gelesis, a biotechnology company at the forefront of developing mechanobiology-based therapies to treat chronic diseases related to the gastrointestinal (GI) system, has received a non-dilutive $10.6 million grant to…